Patients with idiopathic pulmonary arterial hypertension (IPAH) account for approximately 5 percent of all double lung transplants; however lung transplant is commonly performed for patients with PAH associated with chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF), connective tissue diseases and other lung diseases.